Standout Papers

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy 2022 2026 2023 2024341
  1. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy (2022)
    Fan Yang, Yi Xiao et al. Cell Metabolism
  2. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer (2022)
    Yi Xiao, Ding Ma et al. Cell Research

Immediate Impact

1 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Advances in conducting nanocomposite hydrogels for wearable biomonitoring
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
2 intermediate papers

Works of Jia-Han Ding being referenced

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
2022 Standout
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
2020

Author Peers

Author Last Decade Papers Cites
Jia-Han Ding 258 389 449 361 14 827
Zhi-Ming Shao 352 354 453 219 10 836
Lu Tang 168 338 476 283 20 851
Monica Cojoc 431 326 481 145 11 913
Clémentine Le Magnen 342 252 444 426 21 909
Zhefang Wang 322 408 517 176 18 873
Tian‐Jian Yu 286 418 500 145 17 854
Cor van der Leest 283 244 539 393 27 944
Yun‐Song Yang 188 333 430 128 14 670
Caner Ercan 167 353 501 297 22 832
Hye Gyeong Park 304 355 524 120 12 868

All Works

Loading papers...

Rankless by CCL
2026